Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease

被引：32

作者：

Imashuku, S ^{[1
]}

Teramura, T

Morimoto, A

Naya, M

Kuroda, H

机构：

[1] Kyoto City Inst Hlth & Environm Sci, Kyoto, Japan

[2] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 602, Japan

[3] Kyoto City Hosp, Dept Pediat, Kyoto, Japan

来源：

BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 01期

关键词：

D O I：

10.1038/sj.bmt.1704307

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：129 / 130

页数：2

共 7 条

[1] Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy [J].

Castagnola, E ;

Dallorso, S ;

Faraci, M ;

Morreale, G ;

Di Martino, D ;

Cristina, E ;

Scarso, L ;

Lanino, E .

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2003, 12 (01) :9-10

[2] Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children [J].

Faye, A ;

Quartier, P ;

Reguerre, Y ;

Lutz, P ;

Carret, AS ;

Dehée, A ;

Rohrlich, P ;

Peuchmaur, M ;

Matthieu-Boué, A ;

Fischer, A ;

Vilmer, E .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (01) :112-118

[3] Effectiveness of rituximab for chemotherapy- resistant multiple tumoral B-LPD in a haemopoietic stem cell recipient [J].

Imashuku, S ;

Naya, M ;

Tamura, S ;

An, BM ;

Teramura, T ;

Kobayashi, M ;

Nomura, K ;

Taniwaki, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) :771-773

[4] CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation [J].

Kuehnie, I ;

Huls, MH ;

Liu, ZS ;

Semmelmann, M ;

Krance, RA ;

Brenner, MK ;

Rooney, CM ;

Heslop, HE .

BLOOD, 2000, 95 (04) :1502-1505

[5] Treatment of childhood autoimmune haemolytic anaemia with rituximab [J].

Quartier, P ;

Brethon, B ;

Philippet, P ;

Landman-Parker, J ;

Le Deist, F ;

Fischer, A .

LANCET, 2001, 358 (9292) :1511-1513

[6] Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation [J].

van Esser, JWJ ;

Niesters, HGM ;

van der Holt, B ;

Meijer, E ;

Osterhaus, ADME ;

Gratama, JW ;

Verdonck, LF ;

Löwenberg, B ;

Cornelissen, JJ .

BLOOD, 2002, 99 (12) :4364-4369

[7] Treatment of posttransplant lymphoproliferatieve disease with rituximab: The remission, the relapse, and the complication [J].

Verschuuren, EAM ;

Stevens, SJC ;

Van Imhoff, GW ;

Middeldorp, JM ;

De Boer, C ;

Koeter, G ;

The, TH ;

Van Der Bij, W .

TRANSPLANTATION, 2002, 73 (01) :100-104

← 1 →